Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PAVmed Inc. Director's Dealing 2016

May 3, 2016

35221_dirs_2016-05-02_eb18fc53-aae6-4401-beca-4b64b711984b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2016-04-28

Reporting Person: Lamstein Joshua R (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-04-28 Employee Stock Option (Right to Buy) $5.00 A 97554 Acquired 2026-04-28 Common Stock (97554) Direct

Footnotes

F1: The option vests as to 3/36 of the shares on July 28, 2016 and in 33 equal monthly installments thereafter.